Antithrombotic Effect of Oral Administration of Mozuku (Cladosiphon okamuranus, Brown Seaweed) Extract in Rat.

Abstract

Dysfunction of vascular endothelial cells causes the risk of thrombosis. Aim of this study is to evaluate the antithrombotic effect of Okinawa mozuku (brown seaweed, Cladosiphon okamuranus) extract by using cultured vascular endothelial cells and rat carotid arterial thrombosis model induced by ferric chloride (FeCl3). The cell line (TKM-33) established from human umbilical vein endothelial cells were cultured with or without Okinawa mozuku extract. After incubation for 24 h, the conditioned medium was collected to evaluate urokinase-type plasminogen activator (u-PA) activity. Next, rats were fed with water or water containing 5% of Okinawa mozuku extract for 8 wk. After 8 wk of treatments, the rats were provided for the carotid arterial thrombosis model, and fibrinolytic factor and coagulation factor in blood were measured. Okinawa mozuku extract significantly augmented u-PA activity in the conditioned medium. The decrease of carotid artery blood flow induced by 40% FeCl3 injury in rats fed with Okinawa mozuku extract was less than that in control rats. Thus, oral administration of Okinawa mozuku extract prevented thrombus formation in this model. Oral administration of Okinawa mozuku extract significantly increased u-PA activity in euglobulin fraction, compared with control group. On the other hand, platelet aggregation activity, activated partial thromboplastin time, and active PAI-1 level in plasma exhibited no significant differences between control and Okinawa mozuku groups. These results indicate that oral administration of Okinawa mozuku enhances fibrinolytic activity in plasma and prevents thrombus formation which is induced by injury of vascular endothelial cells.

• Authors: Toshinori Yasuzawa, Akira Mima, Shigeru Ueshima
• Journal: Journal of nutritional science and vitaminology (J Nutr Sci Vitaminol (Tokyo)) Vol. 65 Issue 2 Pg. 171-176 ( 2019) ISSN: 1881-7742 [Electronic] Japan
• PMID: 31061286 (Publication Type: Journal Article)

Chemical References

• Fibrinolytic Agents
• Plant Extracts
• Urokinase-Type Plasminogen Activator

Topics

• Administration, Oral
• Animals
• Carotid Artery Thrombosis (metabolism)
• Disease Models, Animal
• Fibrinolytic Agents (administration & dosage, pharmacology)
• Human Umbilical Vein Endothelial Cells
• Humans
• Male
• Phaeophyta
• Plant Extracts (administration & dosage, pharmacology)
• Rats
• Rats, Sprague-Dawley
• Urokinase-Type Plasminogen Activator (drug effects, metabolism)